Crossmark

A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment <i>via</i> inhibiting JAK-STAT and JNK signalling pathways

Crossref DOI link: https://doi.org/10.1039/D0NR05551D

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Wang, Ziqian

Zhan, Chenyue

Zeng, Fang https://orcid.org/0000-0002-6607-3494
Wu, Shuizhu https://orcid.org/0000-0002-6739-0694
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (21875069, 51673066, 21574044)

Natural Science Foundation of Guangdong Province (2016A030312002)
License Information

Accepted Manuscript valid from 2021-10-27
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Fang Zeng (ORCID)

: Shuizhu Wu (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 26 July 2020; Accepted 24 October 2020; Accepted Manuscript published 27 October 2020; Advance Article published 16 November 2020; Version of Record published 26 November 2020